Literature DB >> 17891662

A preliminary comparison of major kinds of obstacles to enrolling in substance abuse treatment (AOD) reported by injecting street outreach clients and other stakeholders.

Philip W Appel1, Rivka Oldak.   

Abstract

Injecting drug users (IDU) (n=144), street outreach (n=55), and treatment program (n=71) staff and managers in stakeholder government agencies (n=11) cited or mentioned many barriers to enrolling in substance abuse treatment (AOD), using varied assessment instruments (1). Here, we aimed to investigate a possible overemphasis on individual client factors (e.g., "readiness," denial) as barriers to enrollment and the relative importance of other kinds of barriers, e.g., limitations using a four-category classification of: individual client factors (IC), treatment accessibility (TAX), treatment availability (AVL), and (lack of) client acceptability (CA), reflecting stigmatization of IDUs. TAX responses predominated for outreach staff (51%), government managers (39%), and barriers implied by client suggestions (52%). IC (60%) followed by TAX (36%) factors characterized barriers clients generated directly. The IC factor thus appears overrepresented among IDUs and TAX is important for all groups suggesting a greater focus on access may be more cost-effective than on individual treatment motivation interventions.

Mesh:

Substances:

Year:  2007        PMID: 17891662     DOI: 10.1080/00952990701522641

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  6 in total

1.  Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program.

Authors:  Zoe M Weinstein; Gabriela Gryczynski; Debbie M Cheng; Emily Quinn; David Hui; Hyunjoong W Kim; Colleen Labelle; Jeffrey H Samet
Journal:  Drug Alcohol Depend       Date:  2018-06-19       Impact factor: 4.492

2.  Inability to access addiction treatment and risk of HIV infection among injection drug users recruited from a supervised injection facility.

Authors:  M-J S Milloy; Thomas Kerr; Ruth Zhang; Mark Tyndall; Julio Montaner; Evan Wood
Journal:  J Public Health (Oxf)       Date:  2009-09-23       Impact factor: 2.341

3.  Possible barriers to enrollment in substance abuse treatment among a diverse sample of Asian Americans and Pacific Islanders: opinions of treatment clients.

Authors:  Carmen L Masson; Michael S Shopshire; Soma Sen; Kim A Hoffman; Nicholas S Hengl; John Bartolome; Dennis McCarty; James L Sorensen; Martin Y Iguchi
Journal:  J Subst Abuse Treat       Date:  2012-09-15

4.  Inpatient addiction consultation and post-discharge 30-day acute care utilization.

Authors:  Zoe M Weinstein; Debbie M Cheng; Maria J D'Amico; Leah S Forman; Danny Regan; Alexandra Yurkovic; Jeffrey H Samet; Alexander Y Walley
Journal:  Drug Alcohol Depend       Date:  2020-05-25       Impact factor: 4.492

5.  Public spending for illegal drug and alcohol treatment in hospitals: an EU cross-country comparison.

Authors:  Delfine Lievens; Freya Vander Laenen; Johan Christiaens
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-06-30

6.  Community social deprivation and availability of substance use treatment and mutual aid recovery groups.

Authors:  Cory M Morton
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-08-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.